Table 1.

Recipient characteristics of the cohort (n=43,514)

Characteristicn (%) or Median (Quartile 1–Quartile 3)
Age at LT (yr)54 (48–60)
Men29,453 (67.7%)
Race
 White31,671 (72.8%)
 African American3967 (9.1%)
 Hispanic5446 (12.5%)
 Asian2076 (4.8%)
 Other354 (0.8%)
Diagnosis
 Hepatitis C19,143 (44.0%)
 Cholestatic liver disease4378 (10.1%)
Pre-LT diabetes9359 (21.5%)
Status-1 at LT2468 (5.7%)
BMI27.4 (24.0–31.4)
Laboratory MELD score19 (14–27)
Serum creatinine at LT1.1 (0.8–1.5)
Serum bilirubin at LT3.8 (1.9–9.5)
INR at LT1.6 (1.3–2.1)
RRT at LT2231 (5.1%)
 RRT≤6 wk at LT2203
 RRT>6 wk at LT28
Nonsteroid induction therapy used9287 (21.3%)
Steroids part of initial maintenance immunosuppression regimen33,634 (77.3%)